Persistent/Recurrent Minimal Residual Disease (MRD)
1 clinical trials · Condition
◉ Watch Persistent/Recurrent Minimal Residual Disease (MRD)
| Record | Firm | Date |
|---|---|---|
| Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL) (NCT02185781) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2015-01-28 |
Track Persistent/Recurrent Minimal Residual Disease (MRD) automatically
Every clearance here is in the API, with alerts when new ones post.